Arthur Zaske & Associates’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$287K Hold
4,207
0.31% 61
2017
Q3
$263K Hold
4,207
0.28% 64
2017
Q2
$233K Buy
4,207
+115
+3% +$5.99K 0.21% 66
2017
Q1
$206K Buy
+4,092
New +$199K 0.15% 71

Other funds holding XYL

Arthur Zaske & Associates's XYL Position: Q4 2017 in Review

Arthur Zaske & Associates held its Xylem (XYL) position steady in Q4 2017 at 4,207 shares worth $287K. The position accounts for 0.31% of the portfolio, ranked #61.

Arthur Zaske & Associates first reported a position in XYL in Q1 2017 and has held it in 4 quarters since. 625 funds tracked by Wall St. Rank hold XYL as of Q4 2017.

  • Arthur Zaske & Associates held 4,207 shares of Xylem worth $287K as of Q4 2017.
  • Arthur Zaske & Associates left its Xylem share count unchanged in Q4 2017.
  • Xylem made up 0.31% of Arthur Zaske & Associates's portfolio in Q4 2017, its #61 holding.
  • Arthur Zaske & Associates first reported a position in Xylem in Q1 2017 and has held it in 4 quarters since.
  • 625 funds tracked by Wall St. Rank held Xylem as of Q4 2017.

Based on Arthur Zaske & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.